West Georgia resident Ella Velez, 15, is among the first pediatric patients in the world to receive the medication, according to a May 23 news release from Atlanta-based Piedmont Healthcare. With the help of endocrinologist Steven Leichter, MD, Ella received infusions for 14 days.
Piedmont Columbus Regional is the first hospital in the U.S. to develop a screening process for patients who might be candidates for Tzield, the release said. In fall 2024, the 24-hospital system will open a children’s hospital that will have the capability to offer the medication to more patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
